Literature DB >> 6776403

Long-term digitalis therapy improves left ventricular function in heart failure.

S B Arnold, R C Byrd, W Meister, K Melmon, M D Cheitlin, J D Bristow, W W Parmley, K Chatterjee.   

Abstract

To clarify the controversy regarding the benefits of long-term oral digoxin in the treatment of heart failure, we evaluated hemodynamics at rest and during exercise in nine patients in sinus rhythm with symptomatic heart failure. Patients were studied during long-term digoxin therapy, after withdrawal of the drug, and six hours after readministration. Upon withdrawal of digoxin, pulmonary capillary-wedge pressure increased from 21 +/- 8 to 29 +/- 10 mm Hg, and cardiac index decreased from 2.4 +/- 0.7 to 2.1 +/- 0.6 liters per minute per square meter of body-surface area, suggesting a deterioration in left ventricular function. In addition, heart rate tended to increase and stroke-work index, stroke-volume index, and radioangiographic ejection fraction decreased. Acute readministration restored the hemodynamic values to those observed during long-term digoxin therapy. The improvement in hemodynamics during long-term digoxin administration was also observed during exercise. This improvement demonstrated the value of long-term oral digoxin therapy in congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776403     DOI: 10.1056/NEJM198012183032503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  53 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  Digoxin after myocardial infarction. Does it have a role?

Authors:  G D Johnston
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 3.  Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Authors:  U Ravens; M Wehr
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 4.  Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

Review 5.  Digitalis for treatment of heart failure in patients in sinus rhythm.

Authors:  William B Hood; Antonio L Dans; Gordon H Guyatt; Roman Jaeschke; John J V McMurray
Journal:  Cochrane Database Syst Rev       Date:  2014-04-28

Review 6.  Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure.

Authors:  J Tauke; D Han; M Gheorghiade
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  [Digitalis therapy: prescription frequency, serum concentrations and withdrawal trials].

Authors:  M Middeke; W Meister; C Krüger; B Krahl; H Holzgreve
Journal:  Klin Wochenschr       Date:  1985-08-16

8.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

9.  Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity.

Authors:  M Inoue; B H Kim; M Hori; Y Tsuneoka; N Matsubara; T Kamada; K Kodama; M Naka; S Nanto; Y Higashino
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

10.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.

Authors:  B E Jaski; M A Fifer; R F Wright; E Braunwald; W S Colucci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.